-
$37.07
This classic work delves into the political and economic dynamics within the cancer establishment, shedding light on controversial issues surrounding cancer treatment and research. It uncovers the forces that shape the industry, prompting readers to consider the implications of these influences on public health and medical practices. Through its compelling narrative, the book challenges conventional perspectives and encourages critical thinking about the cancer treatment landscape.
-
$24.95
“Cancer, Incorporated” by Moss critiques the pharmaceutical industry’s influence on cancer drug development and marketing, arguing that profit motives overshadow the quest for effective treatments. The book examines how Big Pharma manipulates drug production, resulting in minimally effective, unsafe, and overpriced medications. Moss discusses the industry’s corruption of oncology through the influence of key opinion leaders, contributing to a broader understanding of the complexities involved in cancer treatment. This work serves as an important commentary on the challenges posed by the pharmaceutical sector in addressing one of today’s most pressing health issues.
-
$24.95
“The Cancer Industry,” published in 1991, critically examines the cancer treatment establishment, challenging conventional methods and exploring the economic and political factors influencing the industry. The book is divided into four parts, discussing the effectiveness of standard treatments like surgery, radiation, and chemotherapy while considering alternative therapies and the significance of prevention. It serves as an essential resource for those seeking to understand the complexities and controversies surrounding cancer care, urging readers to question established practices and contemplate the future of treatment. The work is published by The Moss Report and spans 450 pages.
